Newman Lauren, Rowland Andrew
College of Medicine and Public Health Flinders University Bedford Park South Australia Australia.
J Extracell Biol. 2025 Jun 22;4(6):e70059. doi: 10.1002/jex2.70059. eCollection 2025 Jun.
Extracellular vesicles (EVs) are nanosized, membrane-bound particles released by virtually all cell types, serving as messengers within tissues and across organs via the bloodstream. EVs encapsulate diverse molecular cargo that reflects the phenotypic state of their originating cells, making them promising candidates for liquid biopsy applications. However, the heterogeneity of circulating EVs, comprising particles from various cell types and non-vesicular entities like lipoproteins, poses significant challenges for isolating tissue-specific EV populations. This review examines current methodologies for detecting and isolating tissue-specific EVs from blood, focusing on immunoaffinity capture (IAC) strategies that leverage surface marker expression for specificity. Key considerations, including the selection and validation of markers, are discussed alongside advances in EV subtyping and isolation protocols. Challenges such as marker cross-reactivity, EV biogenesis and transport dynamics are highlighted to underscore the complexity of achieving clinical utility. By providing an overview of validated tissue-specific markers and isolation techniques, this review aims to facilitate the development of EV-based biomarkers with enhanced specificity and sensitivity, enabling minimally invasive monitoring of organ function and disease.
细胞外囊泡(EVs)是几乎所有细胞类型释放的纳米级膜结合颗粒,通过血液循环在组织内和跨器官充当信使。EVs包裹着反映其来源细胞表型状态的各种分子货物,使其成为液体活检应用的有前景的候选者。然而,循环EVs的异质性,包括来自各种细胞类型的颗粒和脂蛋白等非囊泡实体,给分离组织特异性EV群体带来了重大挑战。本综述探讨了从血液中检测和分离组织特异性EVs的当前方法,重点关注利用表面标志物表达实现特异性的免疫亲和捕获(IAC)策略。讨论了关键考虑因素,包括标志物的选择和验证,以及EV亚型分类和分离方案的进展。强调了标志物交叉反应性、EV生物发生和运输动力学等挑战,以突出实现临床应用的复杂性。通过概述经过验证的组织特异性标志物和分离技术,本综述旨在促进具有更高特异性和灵敏度的基于EV的生物标志物的开发,实现对器官功能和疾病的微创监测。